Yrs. Since vaccination | Vaccination status | N | Vaccine types (HPV16/18) | Cross-protective types (HPV31/33/45) | ||||
---|---|---|---|---|---|---|---|---|
# infections | PR per 100 PY (95%CI) | PRR (95%CI) | # infections | PR per 100 PY (95%CI) | PRR (95%CI) | |||
2 | Unvaccinated | 551 | 2 | 0.18 (0.05–0.73) |  | 2 | 0.18 (0.05–0.73) | Ref |
 | Vaccinated | 626 | 0 | 0.00 (0.00–0.59) |  | 1 | 0.08 (0.01–0.57) | 0.44 (0.04–4.85) |
3 | Unvaccinated | 513 | 2 | 0.19 (0.05–0.78) |  | 2 | 0.19 (0.05–0.78) | Ref |
 | Vaccinated | 567 | 0 | 0.00 (0.00–0.65) |  | 2 | 0.18 (0.04–0.71) | 0.90 (0.13–6.42) |
4 | Unvaccinated | 472 | 7 | 0.74 (0.35–1.56) |  | 4 | 0.42 (0.16–1.13) | Ref |
 | Vaccinated | 515 | 0 | 0.00 (0.00–0.72) |  | 3 | 0.29 (0.09–0.90) | 0.69 (0.15–3.074) |
5 | Unvaccinated | 455 | 10 | 1.10 (0.59–2.04) |  | 3 | 0.33 (0.11–1.02) | Ref |
 | Vaccinated | 472 | 0 | 0.00 (0.00–0.78) |  | 1 | 0.11 (0.01–0.75) | 0.32 (0.03–3.09) |
6 | Unvaccinated | 447 | 18 | 2.01 (1.27–3.20) | Ref | 12 | 1.34 (0.76–2.36) | Ref |
 | Vaccinated | 438 | 1 | 0.11 (0.02–0.81) | 0.06 (0.01–0.42) | 2 | 0.23 (0.06–0.91) | 0.17 (0.04–0.76) |
7 | Unvaccinated | 433 | 11 | 1.27 (0.70–2.99) | Ref | 5 | 0.58 (0.24–1.39) |  |
 | Vaccinated | 448 | 2 | 0.22 (0.06–0.89) | 0.18 (0.04–0.79) | 0 | 0.00 (0.00–0.82) |  |
8 | Unvaccinated | 414 | 6 | 0.72 (0.33–1.61) |  | 9 | 1.09 (0.57–2.09) | Ref |
 | Vaccinated | 429 | 0 | 0.00 (0.00–0.86) |  | 5 | 0.58 (0.24–1.40) | 0.54 (0.18–0.60) |